Login/Sign Up
How should acute, irregular tachycardia (130?150 bpm) following the initiation of orciprenaline and rosuvastatin be managed in a patient with pre-existing bradycardia and a 1.91-second Holter pause, what are the immediate clinical risks, and does this clinical presentation suggest a need for a permanent pacemaker?
How should acute, irregular tachycardia (130?150 bpm) following the initiation of orciprenaline and rosuvastatin be managed in a patient with pre-existing bradycardia and a 1.91-second Holter pause, what are the immediate clinical risks, and does this clinical presentation suggest a need for a permanent pacemaker?
Answered 20 days ago